Skip to content
Home - Clinical trials - Products in Development - AZD2624    
AZD2624 Ongoing Studies

A number of clinical trials with AZD2624 Ongoing studies are currently in progress.

More studies will be added in due course. Additional AZD2624 Ongoing study information is available on ClinicalTrials.gov.

Study NumberStudy PhaseStart DateRecruitment Status
D0970C00004Phase II12 May 2008Recruiting
A Phase IIa, Double-blind, Double-Dummy, Placebo-controlled, Randomized, Parallel-Group Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of AZD2624 in Adult Schizophrenia Patients
D0970C00006Phase I26 May 2008Recruiting
A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2624 when given in multiple ascending oral doses in young healthy male Japanese subjects.
AstraZeneca websites
Search
Corporate Responsibility
Quick links - Products
Page tools
>
>
>
>